Desmopressin therapy for massive hemoptysis associated with severe leptospirosis

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 5, 2003, Pages 726-728

  Pea, Laurent ^a   Roda, Laurent ^a   Boussaud, Véronique ^a   Lonjon, Bernard ^a  

^a Centre Hospitalier Territorial Papeete   (French Polynesia)

Author keywords

Hemorrhage; Hemostatics; Receptors; Respiratory distress syndrome; Vasopressin; Weil's disease

Indexed keywords

DESMOPRESSIN; ARGIPRESSIN[1 DEAMINO]; HEMOGLOBIN; HEMOSTATIC AGENT; SODIUM;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; HEMOPTYSIS; HUMAN; INTENSIVE CARE; LEPTOSPIROSIS; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SHOCK; TREATMENT OUTCOME; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; BLOOD; COMPARATIVE STUDY; INFUSION; THROMBOCYTE COUNT; TIME;

ADOLESCENT; ADULT; DEAMINO ARGININE VASOPRESSIN; HEMOGLOBINS; HEMOPTYSIS; HEMOSTATICS; HUMANS; INFUSIONS, PARENTERAL; MULTIPLE ORGAN FAILURE; PLATELET COUNT; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SODIUM; TIME FACTORS; WEIL DISEASE;

EID: 0037364285     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200205-450CR     Document Type: Article

References (21)

1. Levett PN. Leptospirosis. Clin Microbiol Rev 2001;14:296-326.
2. Singh SS, Vijayachari P, Sinha A, Sugunan AP, Rasheed MA, Sehgal SC. Clinico-epidemiological study of hospitalized cases of severe leptospirosis. Indian J Med Res 1999;109:94-99.
3. Marotto PC, Nascimento CM, Eluf-Neto J, Marotto MS, Andrade L, Sztajnbok J, Seguro AC. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999;29:1561-1563.
4. Yersin C, Bovet P, Merien F, Clement J, Laille M, Van Ranst M, Perolat P. Pulmonary haemorrhage as a predominant cause of death in leptospirosis in Seychelles. Trans R Soc Trop Med Hyg 2000;94:71-76.
5. Panaphut T, Domrongkitchaiporn S, Thinkamrop B. Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis 2002;6:52-59.
6. Seijo A, Coto H, San Juan J, Videla J, Deodato B, Cernigoi B, Messina OG, Collia O, De Bassadoni D, Schtirbu R, et al. Lethal leptospiral pulmonary hemorrhage: an emerging disease in Buenos Aires, Argentina. Emerg Infect Dis 2002;8:1004-1005.
7. Bethlem EP, Carvalho CR. Pulmonary leptospirosis. Curr Opin Pulm Med 2000;6:436-441.
8. Nicodemo AC, Duarte MI, Alves VA, Takakura CF, Santos RT, Nicodemo EL. Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia. Am J Trop Med Hyg 1997;56:181-187.
9. Bilton D, Webb AK, Foster H, Mulvenna P, Dodd M. Life threatening haemoptysis in cystic fibrosis: an alternative approach. Thorax 1990;45:975-976.
10. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997;90:2515-2521.
11. Sutor AH. DDAVP is not a panacea for children with bleeding disorders. Br J Haematol 2000;108:217-227.
12. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-2963.
13. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-1652.
14. Courtin JP, Di Francia M, Du Couedic I, Poubeau P, Mahe C, Bapteste J, Arvin-Berod C. Respiratory manifestations of leptospirosis: a retrospective study of 91 cases (1978-1984). Rev Pneumol Clin 1998;54:382-392.
15. Trivedi SV, Chavda RK, Wadia PZ, Sheth V, Bhagade PN, Trivedi SP, Clerk AM, Mevawala DM. The role of glucocorticoid pulse therapy in pulmonary involvement in leptospirosis. J Assoc Physicians India 2001;49:901-903.
16. Gilad J, Borer A. Treatment of acute lung injury attributed to leptospirosis. Clin Infect Dis 2000;31:844.
17. Kaufmann JE, Oksche A, Wollheim CB, Gunther G, Rosenthal W, Visher UM. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest 2000;106:107-116.
18. Lethagen S, Frick K, Sterner G. Antidiuretic effect of desmopressin given in hemostatic dosages to healthy volunteers. Am J Hematol 1998;57:153-159.
19. Balduini CL, Noris P, Belletti S, Spedini P, Gamba G. In vitro and in vivo effects of desmopressin on platelet function. Haematologica 1999;84:891-896.
20. De Francesco Daher E, Oliveira Neto FH, Ramirez SM. Evaluation of hemostasis disorders and anticardiolipin antibody in patients with severe leptospirosis. Rev Inst Med Trop Sao Paulo 2002;44:85-90.
21. Lethagen S, Olofsson L, Frick K, Berntorp E, Bjorkman S. Effect kinetics of desmopressin-induced platelet retention in healthy volunteers treated with aspirin or placebo. Haemophilia 2000;6:15-20.